Objective
"Cancer is a common and life-threatening disease with world-wide occurrence, and the number of affected individuals and morbidity continues to increase annually. It is therefore of great importance that straightforward syntheses of potential anti-cancer agents are developed in order to advance treatment and drug discovery in this field. The disorazoles, the subject of this proposal, are a group of natural products which display strong anticancer activity against a variety of cell lines, including multidrug resistant cells. Although one total synthesis and several approaches have been published towards the key family member disorazole C1, these are lengthy and poor-yielding. Consequently, a more-detailed investigation of the mode of action of this highly potent tubulin inhibitor has been severely hampered. The synthetic approach outlined in this proposal will dramatically increase the convergency of synthesis and will allow us to explore how changes in one of the key structural features affects the natural product structure and function. Working in the Hulme group laboratories, the Fellow will synthesise the disorazole C1 analogues with a pioneering approach to construction of the macrolactone core. Using computational modelling and a range of traditional and cutting-edge technologies (X-Ray, NMR and IM-MS) he will study the analogues' structures and tubulin-binding abilities. The Fellow will conduct biological tests including cell-based assays in-house, exploiting the world-leading expertise and facilities within EaStCHEM. The project is thus ideally placed to offer the Fellow a broad interdisciplinary training and give him new insights into both traditional and modern chemical biology and medicinal chemistry techniques. He will attend a series of training courses, tutor and lecture to undergraduates, and exercise considerable supervisory responsibility within the research group; thus enhancing his long-term prospects of becoming an independent academic researcher."
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- medical and health sciences basic medicine medicinal chemistry
- medical and health sciences clinical medicine oncology
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance multidrug resistance
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2011-IEF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
EH8 9YL Edinburgh
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.